The Secrets to Implementing a Successful Metrics Program...• Ensure all trial deliverables are met...
Transcript of The Secrets to Implementing a Successful Metrics Program...• Ensure all trial deliverables are met...
The Secrets to Implementing a
Successful Metrics Program
Ravin Warnakulasuriya
Sr. Director Vertex Pharmaceuticals
MCC Clinical Trial Risk and Performance
Management Summit
The Loews Philadelphia Sept 4-5th 2019
©2018 Vertex Pharmaceuticals Incorporated
1 ©2018 Vertex Pharmaceuticals Incorporated
Agenda
• Finding your Data
• Data Bad Habits / Data Ailments• Data Indigestion
• Data Hoarding
• Data Dilution
• Data Control• Third Party Data
• Vendor Management
• Subscriptions and Data Dilution
• Data Culture (The Human Element)• The Technology Illusion
• The Human Technology Interdependency
• Data Control (who do you trust)
• The 4 Pillars to Establishing a Data Culture
©2018 Vertex Pharmaceuticals Incorporated2
The Data Wood for the Technology Trees
©2018 Vertex Pharmaceuticals Incorporated3
• Emerging Concepts
• Risk (Hype Curve)
• Early Adopter
• Increased responsibility
(adopter vs user)
• Closed Systems
• Confined Data
• Multiple vendors
• eClinical
• Best in Breed
• Business / Financial Driver
• Coalition pros and cons
• Tactical vs Partnership
• Product Roadmap
• Bottled Water (onboarding vs new service)
• Its YOUR data, you only need the data and
you’re entitled to it
• Be System Agnostic
• Be Vendor Agnostic
• Accessibility Right
• Accountability
Back to Basics: Reclaiming your Data
The Hype Cycle
©2018 Vertex Pharmaceuticals Incorporated5
Hype Cycle
©2018 Vertex Pharmaceuticals Incorporated6
Bad Habits
©2018 Vertex Pharmaceuticals Incorporated7
1. Consume your Data like you would consume your food!
©2018 Vertex Pharmaceuticals Incorporated8
• CDW = communal
kitchen refridgerator
• Who’s is it?
• How was it prepared?
• Is it still good?
• How old is it?
• What needs to be
thrown out?
• Does it smell funny?
2. Data Hoarding is Unhealthy
©2018 Vertex Pharmaceuticals Incorporated9
Data Indigestion
©2018 Vertex Pharmaceuticals Incorporated10
• Data Noise
• Data Purity / Data Relevence
• Muddying the waters (Averages, medians)
• Inconsistency in Governance over time
• Meshing and Mapping efforts
• Orphan data
• Public data and its assumptions
• Benchmarking and Big Data Dilution
• Swimming against the legacy current
• Data evolves with the company
• Be Picky with your Data
• Standardization efforts keep us honest
• Out of the box vs configuration
• Canonicals as standard onboarding
• Circle of Life (take what you need)
• Qualify it before ingesting it
• Data Integrity Score• System
• Process
• People
• Validation
• Cleanliness is next to Godliness.
• Data ‘Value Proposition’
Data Selection
Third party Data – a Hostage Situation
©2018 Vertex Pharmaceuticals Incorporated11
• Third Party data• CROs
• Technology vendors
• Subscriptions / Data brokers
• Bells and Whistles• Canned Reports are still canned
• Report Builders
• Dashboards
• APIs and ETLs• APIs are no longer shiny
• Expect it from your Partners
• The Onboarding Advantage• RFIs and RFPs
• Using Canonicals
• It’s YOUR Data!!!
Third Party Data
©2018 Vertex Pharmaceuticals Incorporated12
• Buying Data ( Data subscriptions)
• Public data• Broad inferences (Informed decision)
• Industry data• What’s your Commitment
• What’s your return
• Definitions
• Beneath the surface• The devil is in the details
• Volume for Validity
• Study designs getting more complex
• Are we truly all operating the same?
• The deeper you go, the narrower it
gets
• Normalization and Vendor Agnosticism• Consider your vendor strategy / portfolio
• Aggregation vs Configuration
• Knowing when to Normalize your Data
• Using Canonicals across vendors
Question . . .
1. Is your Third Party Data managed / accessed differently from the
rest of your data?
2. Do you have APIs and data provision requirements as part of
your vendor selection criteria or RFI / RFP Process?
3. For those of you who have APIs set up, do you pay for this?
4. Do you mix your third party data with the rest of your data /
dashboards?
©2018 Vertex Pharmaceuticals Incorporated13
The man Element – Data Culture
©2018 Vertex Pharmaceuticals Incorporated14
Hu
The Technology Illusion
©2018 Vertex Pharmaceuticals Incorporated15
©2018 Vertex Pharmaceuticals Incorporated17
Purpose / Need
Data
Provider /
Access
Data
Interpreter
Data
Analyzer
Data
Keeper
Data
Owner
Data
Inferences
Decision
Maker
Options Action
“Even a driverless car
Still needs a passenger”
Calculations Context
Data Driven Emotional
The 4 Pillars of Establishing a Data-Driven Culture
DATA
ACCOUNTABILITY
DATA
TRANSPARENCY.
DATA
INTERPRETATION
DATA
ANALYTICS
Data
Culture
1. Accountability, Responsibility and Support
ROBUST GOVERNANCE MODEL
• Champions (Executive Support)
• Data Owners (Functional Accountability)
• Sys .Owners (Tech Perf. & Enhancements)
• Stewards (User Input, Diagnostics, Champ)
• Process Owners (Formal Adherence)
• Trainers (Awareness)
INVESTMENTS
• Talent
• Bandwidth
• Financial
EMBEDDED BUSINESS MODEL
• Integrated IT/Business Operations
• Integrated IT/Business Strategy
• Cadence and Committees (Operational /
Steering)
DATA ACCOUNTAIBILITY
2. Transparency, Trust and Co-Dependency
• Trust
• Data Sharing
• Xfunctional Dependency
• Single Source of Truth culture
• Data Integrity
• Trusting the Source / Owner
• Data Origins / Definitions / Logic
Accessibility
• Appropriateness
• Ease of Access
• Integration / Formalization
• Formal Process
• Marketing
• Adoption and Expansion
DATA TRANSPARENCY
3. Analysis, Access and Autonomy
• Robust visualizations
• Interactive user autonomy
• Interoperability (meshed reports)
• Accessibility Appropriateness
• User Friendly (internet, exports)
• Up to date (nightly feeds)
• Diagnostics (alerts and reports)
• Intended Uses• What questions are being
asked?
• Problem vs Solution oriented
• Exploratory vs Purposeful• Data Developers
• Data Scientists
DATA ANALYTICS
4. Application, Understanding and Action
• Meaningful Metrics
• Actionable outcomes
• Measurable
• Data Driven Decisions
• Reaction and Context• Risk reporting (R/A/G signals)
• Metadata vs Text
• Emotional Quotient
• (Adoption / Application)• Exposure (reluctance)
• Paranoia (delays)
• Defensive (downplay)
• Chore vs Tool (deprioritize)
• Adopter (dependent)
DATA INTERPRETATION
Question . . .
1. Does your company have a robust Data Culture?
2. Do you have a formal Data Governance Model?
3. Do you trust the data that you don’t own?
4. Are you willing to surface your Data to Executive Management?
©2018 Vertex Pharmaceuticals Incorporated23
Summary
©2018 Vertex Pharmaceuticals Incorporated24
• Find your Data
• Be Data Healthy and Hygienic
• Free your Data
• Find your sweet spot• Depth vs Breadth
• Volume vs Validity
• Configuration vs Standardization
• Data Agnosticism• Use Canonicals
• Data Accountability
• Establish a Data driven Culture
Questions?
©2018 Vertex Pharmaceuticals Incorporated25
Secrets to Implementing Successful Metrics Programs
Mike Fitzpatrick04 Sep 2019
Agenda
Poll Question
My Analytics Journey – Challenges and Recommendations
Case Study - Treehouse Brewing
Key Takeaways
Clinical trial teams excel at
leveraging data in my company.
“The ability to take data – to be able to understand it, to process it, to extract value from it, to visualize it, to communicate it’s going to be a hugely important skill in the next decades”
Google’s Chief Economist Hal Varian – 2009 Interview
Poll Question:
Strongly Agree
5
Agree 4
Neither 3
Disagree 2
Strongly Disagree
1
Traditional Clinical Trial Manager Skills &
Qualifications
do not optimize
Clinical Trial Execution
My Hypothesis….
Responsibilities (Trial Execution)
• Day to day management of assigned clinical trial to ensure deliverables are met in all phases of trial
• Communication to internal team members on deliverables and ensuring timelines are met
• Manage trial feasibility process
• Work closely with Rare Disease or Infectious Disease Clinical Operations Strategy Leader to implement Operations plan for Clinical Study Teams.
• Drafting site materials including training, manuals and support documentation
• Monitoring of clinical data to ensure timely entry and readiness for data review meetings
• Periodic review of clinical data
• Review of clinical monitoring reports to ensure timely completion and identification of issues
• Ensure trial samples are ready to be sent to vendors in order to meet trial deliverables
• Maintain trial metrics
• Ensure trial is conducted in accordance to company and ICH/GCP standards including multiple regions in global trials
• Support the CRO in testing clinical trial systems/databases (i.e. UAT)
• Develop and maintain strong, collaborative relationships with key stakeholders within company
• Lead strategic planning and management of all study and team activities, leveraging internal and development partner resources, expertise and knowledge, along with optimizing CRO resources, expertise and knowledge.
• Lead development of overall clinical strategic operations plan for assigned projects including timelines, internal and external costs, CRO/Vendor Oversight Plans, key deliverables and risk/mitigation strategy.
• Provide oversight of study timelines and trial execution.
• Ensure all trial deliverables are met according to timeline, budget, and resource requirements
• Partner closely with Clinical Research Organization (CRO) interactions, including sponsor oversight of relevant functional activities (e.g., study management, monitoring, site management, and project master files).
• Monitor oversight of study progress including: CRO and third party vendors, ensuring compliance with relevant regulations and guidelines by maintaining regular contact with external vendors, including CRAs, as applicable.
• Work with CRO to develop and/or revise scope of service agreements, budgets, plans and detailed timelines and ensures that performance expectations are met.
• Collaborate with internal medical director in development and authorship of study protocol
• Participate in Case Report Form design, user acceptance testing in partnership with Data Management.
• Execute CRO/Third Party Oversight Activities including but not limited to: Monitoring visit report review, periodic review of data quality, review of CRO/Vendor KPIs, performing Sponsor Oversight Visits, etc.
• Contribute to and/or author clinical sections of regulatory documents including Investigators’ Brochures, safety updates, and responses to Health Authority / Ethics Committee questions
• Identify potential study issues, proactively recommending and implementing solutions or corrective actions, as needed.
• Develop and actively manage Site/Investigator relationships; serve as a liaison and resource.
• Organize, schedule and attend internal & external team trial-specific meetings.
• Perform occasional travel to CRO/vendor facilities and/or investigative sites to train and assess study team and CRAs.
• Assist Senior Clinical Trial Manager in management of clinical programs, preparation and execution of sound clinical development strategies, and Clinical Operations Department Initiatives.
• Participate in the development, review and implementation of departmental SOPs and processes.
• Other Job-related duties as assigned.
Job Description #1 (Biotech ~700 employees): Job Description #2 (Pharma ~2500 employees):
Two randomly selected CTM job postings from Linkedin, Aug 2019
• Day to day management of assigned clinical trial to ensure deliverables are met in all phases of trial
• Communication to internal team members on deliverables and ensuring timelines are met
• Manage trial feasibility process
• Work closely with Rare Disease or Infectious Disease Clinical Operations Strategy Leader to implement Operations plan for Clinical Study Teams.
• Drafting site materials including training, manuals and support documentation
• Monitoring of clinical data to ensure timely entry and readiness for data review meetings
• Periodic review of clinical data
• Review of clinical monitoring reports to ensure timely completion and identification of issues
• Ensure trial samples are ready to be sent to vendors in order to meet trial deliverables
• Maintain trial metrics
• Ensure trial is conducted in accordance to company and ICH/GCP standards including multiple regions in global trials
• Support the CRO in testing clinical trial systems/databases (i.e. UAT)
• Develop and maintain strong, collaborative relationships with key stakeholders within company
• Lead strategic planning and management of all study and team activities, leveraging internal and development partner resources, expertise and knowledge, along with optimizing CRO resources, expertise and knowledge.
• Lead development of overall clinical strategic operations plan for assigned projects including timelines, internal and external costs, CRO/Vendor Oversight Plans, key deliverables and risk/mitigation strategy.
• Provide oversight of study timelines and trial execution.
• Ensure all trial deliverables are met according to timeline, budget, and resource requirements
• Partner closely with Clinical Research Organization (CRO) interactions, including sponsor oversight of relevant functional activities (e.g., study management, monitoring, site management, and project master files).
• Monitor oversight of study progress including: CRO and third party vendors, ensuring compliance with relevant regulations and guidelines by maintaining regular contact with external vendors, including CRAs, as applicable.
• Work with CRO to develop and/or revise scope of service agreements, budgets, plans and detailed timelines and ensures that performance expectations are met.
• Collaborate with internal medical director in development and authorship of study protocol
• Participate in Case Report Form design, user acceptance testing in partnership with Data Management.
• Execute CRO/Third Party Oversight Activities including but not limited to: Monitoring visit report review, periodic review of data quality, review of CRO/Vendor KPIs, performing Sponsor Oversight Visits, etc.
• Contribute to and/or author clinical sections of regulatory documents including Investigators’ Brochures, safety updates, and responses to Health Authority / Ethics Committee questions
• Identify potential study issues, proactively recommending and implementing solutions or corrective actions, as needed.
• Develop and actively manage Site/Investigator relationships; serve as a liaison and resource.
• Organize, schedule and attend internal & external team trial-specific meetings.
• Perform occasional travel to CRO/vendor facilities and/or investigative sites to train and assess study team and CRAs.
• Assist Senior Clinical Trial Manager in management of clinical programs, preparation and execution of sound clinical development strategies, and Clinical Operations Department Initiatives.
• Participate in the development, review and implementation of departmental SOPs and processes.
• Other Job-related duties as assigned.
Job Description #1 (Biotech ~700 employees): Job Description #2 (Pharma ~2500 employees):
Legend:Tasks improved with data skill set
Skills and Qualifications
• At least 5 five years of trial coordination experience in a clinical research environment, some should be in industry
• Advanced degree preferred or Bachelor’s in a science-based subject
• Relevant therapeutic experience in global setting
• Solid understanding of drug development
• Good project management skills
• Good understanding of FDA and ICH GCP guidelines to ensure the appropriate conduct of clinical studies
• Excellent verbal and written communication skills
• Good organizational skills and attention to detail
• BS/BA degree in science or similar area.
• 2-5 years’ experience as integral Team support for clinical trials for or within the biotech or pharmaceutical industry, including CRO/vendor management, monitoring of budget scope, clinical site monitoring, protocol, ICF, CRF, CSR development and review and knowledge of basic data management/biostatistics processes including Electronic Data Collection (EDC) and Pharmacovigilance.
• Knowledge of global clinical trial management in fast paced CRO outsourced environment, including interpretation and implementation of FDA regulations/ICH guidelines, is required.
• Excellent oral and written communications.
• Ability to establish study operational plans and strategy. Requires a balance of scientific and operational/project management and team leadership expertise.
• Strong computer skills including knowledge of Microsoft Excel, Word, PowerPoint and Outlook.
• Ability to work within established timelines, in a fast paced environment.
• Excellent organizational and priority management skills.
• Good interpersonal skills and ability to deal with people at all levels with sensitivity and tact.
• Prior CNS or gene therapy experience preferred.
Job Description #1 (Biotech ~700 employees): Job Description #2 (Pharma ~2500 employees):
Legend:Data or technology related skills
Two randomly selected CTM job postings from Linkedin, Aug 2019
• Embedded within the clinical trial team
• Change management is built in – because the change is coming from embedded team
Thinking Different about Resourcing for Clinical Operations
https://www.linkedin.com/jobs/view/digital-innovator-urovant-at-roivant-sciences-866413569/
My Analytics Journey
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Studied Industrial Engineering
Joined Biogen as Clinical Operations Supply Manager
Cross trained with Clinical Trial Managers and Co-Monitors/CRAs
Clinical Supply SME for FDA, MHRA, PMDA Inspections
Transitioned to Clinical Operations Capabilities Performance team
Metrics and Analytics lead for:• CRO Oversight and
Partnership/Functional Metrics• Program and Study Reporting• Study Planning and Baseline Analytics• Site satisfaction (NPS)• Ad-hoc decision support
Joined Sarepta to build out Clinical Systems and Analytics capabilities
CLINICAL OPERATIONS DATA & ANALYTICS BUILDING
Challenges to Data and Analytics Success
DEPENDENT BLACK BOX UNCERTAIN CONFUSING SLOW
Relied on IT or vendors to produce dashboards/report Clin Ops as business
owner
Development was a “black box”
Did not understand what data are
available and what kind of reports were possible
“I’ll know it when I see it”
No one knew what they wanted –people want to
explore
Technical people did not understand clinical operations
or data visualization/
storytelling best practices
Deliverables took months to create and often needed to be re-worked
First 6-12 months
• Full of distractions
• Too much information
• Too many colors make it difficult to concentrate
• Difficult to take information in at a glance
• Visually appealing, but not distracting
• Nice color scheme – red colors to highlight important call-outs
• No unnecessary charts/data
• Filters make it easy to access necessary data
https://www.bigbookofdashboards.com/https://adniasolutions.com/dashboard-design-principles/introduction-to-dashboards/
What I was receiving… What I wanted….
My Recommendations
DATA
Understand and prepare your data assets
TOOLS & PEOPLE
Embed self-service analytics capabilities
within clinical operations organization
SO WHAT
Focus on key questions and related actions
before metric definitions
Recommendations:
• Request that your CRO or vendor provide access raw data programmatically or data transfer
• Ask what can they provide in weeks not months
• Do not be picky on the format or structure - whatever is easier for them
• Negotiate to include any missing data as second phase (or if they charge for initial transfer be more comprehensive in data ask)
Why it’s Important:
• Answer questions independently
• Drill into data for root cause investigation
• Don’t duplicate data tracking efforts with CRO
• Build new reports and dashboards
• Leverage vendors more strategically
• Rather than data cleaning, spend more time on meaningful analysis and innovation: machine learning, NLP, etc.
• Hire or develop experts in self-service data preparation and data visualization
• Be able to understand business problems and build reproducible data/technology solutions in days not weeks or months.
What is self-service?
What are the capabilities/ use
cases?
What are some tools/software?
• Teams will want lots of metrics if you just ask them what they want to use for metrics
• Much harder for teams to answer: • What is the question to answer?
• Why is it important?
• What action to take?
Metrics Methodology
Strategy Map
Example of SharePoint
Analytics Portal
‹#›
Treehouse Brewing Case Study
‹#›
Source Data: 2+ years of daily can releases: tracked diligently by Facebook group member
‹#›
‹#›
What are the key questions?
• What is the best day to go if I want the best beer variety?
• What beer is most likely to be available to buy? Which should I buy?
• How much is it likely to cost me?
‹#›
Key Takeaways
DATA
Understand and prepare your data assets
TOOLS & PEOPLE
Embed self-service analytics capabilities
within clinical operations organization
SO WHAT
Focus on key questions and related actions
before metric definitions
• Set up data transfers with CROs• Define data model + quality checks• Create a data dictionary
• Select a tool(s) (software)• Embed analysts to support teams• Promote data visualization and
storytelling best practices
• Brainstorm and strategy map• Rapid development and iteration • Create website for sharing content
Measuring Quality of Clinical
Development ProcessesNancy Dynes, Quality Metrics Consultant
Medicines Quality Organization
Intro
Disclaimer
• These slides and the content of this presentation represent the work and opinions of the
author and do not constitute official positions of Eli Lilly & Company or any other
organization.
• This document provides an outline of a presentation and is incomplete without the
accompanying oral commentary and discussion.
• Graphics, figures and data contained herein are for illustrative purposes and are not
representative of actual data.
About Me
• Experience
• Current Role
9/5/2019 ©2019 Eli Lilly and Company 54
Metrics Project Kickoff
9/5/2019 ©2019 Eli Lilly and Company 55
Process & Quality Metric Evolution
• Clinical development operational metrics are
often focused on efficiency and productivity
• Processes must also be evaluated for quality
and effectiveness
12/6/2018 ©2018 Eli Lilly and Company 56
CD System Structure
• The quality system is integrated into a cross-functional
“operating system” that differentiates regulatory
requirements from business requirements.
• The document management system is structured to
enable linkages to the SOPs.
• A search engine overlays process maps and
documents to help end users find content/guidance
across multiple elements of the system.
12/6/2018 ©2018 Eli Lilly and Company 57
Document Repository
• Procedures and required tools are created only
for requirements as defined in the operating
system.
• All documents are linked to their step in the
corresponding process flow using metadata.
• Metadata is output to the deviation
management system.
12/6/2018 ©2018 Eli Lilly and Company 58
Document Metadata
12/6/2018 ©2018 Eli Lilly and Company 59
The storage system
provides descriptive fields
for each SOP. The
metadata then follows the
document into the
deviation management
system.
Systems Running
• When departures from the requirements are
found, a deviation is created.
– Variations in business processes that do not represent a
departure from quality system requirements do not drive
deviations.
• Deviations are robustly linked to the processes
and quality system documents via metadata.
• Method is in place to assess conformance to the
process/requirements.12/6/2018 ©2018 Eli Lilly and Company 60
Measuring Conformance
Problem: Deviation data are difficult to interpret
in their native form.
Solution: Use a visualization tool to build a
dashboard that summarizes deviations according
to the processes in the operating system
12/6/2018 ©2018 Eli Lilly and Company 61
Occurrences Over Time
• Measure the absolute
number of deviations
per topic per quarter
• Identify which are
above a trigger value
or increasing over
time
12/6/2018 ©2018 Eli Lilly and Company 62
Doc Process
Process
Area
Threshold
Met
2017
Q4
2018
Q1
2018
Q2
2018
Q3
Process 1 Medical Yes 19 6 15 14
Process 12 Medical Yes 9 11 13 17
Process 21 Medical Yes 13 6 4 6
Process 5 Medical Yes 5 7 13 14
Process 12 Medical No 1 1 4 1
Process 7 Medical No 0 1 2 3
Process 30 Medical No 2 2 0 1
Process 3 Medical No 3 1 1 0
• Review subtopics. If necessary, separate further by
country or disease state.
Dig Deeper
12/6/2018 ©2018 Eli Lilly and Company 63
This one needs a
further look as the
deviations are
increasing
This one is
ok to monitor
over time
Process 12
Outputs of Review
• Trends identified in the deviation analysis are
reviewed by quality and process owners to
discern if there are any underlying problems.
• Process owners identify areas in need of
further investigation or change.
• All areas monitored over time by quality and
review boards.
12/6/2018 ©2018 Eli Lilly and Company 64
Outcomes
• Process owners and management value the
more robust outputs
• Process improvements are identified and
tracked
• SOP metadata and deviation quality has
improved
• Focused improvements are based on
systematic reviews12/6/2018 ©2018 Eli Lilly and Company 65
Caveats
• Analyses are limited to quantities only.
• True statistical significance not possible (no
underlying population, no normal distributions,
only errors recorded).
• Deviation volume may vary depending on
business activities.
12/6/2018 ©2018 Eli Lilly and Company 66
Ongoing
• Quality and process owner partnership is
needed to correctly identify where the problems
have occurred.
• Users learning how to use the data outputs
appropriately as an initial investigative tool.
• Data stewards monitoring metadata to ensure
proper linkages as processes are updated.
12/6/2018 ©2018 Eli Lilly and Company 67
Summary
• Use documentation tools to link deviation findings
directly to processes.
• Create a way to monitor the deviations by process
over time to identify areas in need of improvement.
• Implement changes based on data (regulations and
deviations) instead of anecdotes.
12/6/2018 ©2018 Eli Lilly and Company 68
12/6/2018 ©2018 Eli Lilly and Company 69
Bonus Learnings
Design
• Start simple
• Definitions are crucial– First Patient In or First Subject Visit?
– What’s an “Active Trial”?
• Definitions need to be clear and available to end users
• No matter how carefully you design, someone will question your
data and the resulting measures
• Keep in mind: What is the question that you’re trying to answer?
9/5/2019 ©2019 Eli Lilly and Company 70
Data
• Identify data sources
– Reliable
– Current
– Accessible
• Find your data experts and assign a data wrangler
• Degrees of separation between those who input data
and those who use it downstream may introduce
challenges
• Static data rarely is9/5/2019 ©2019 Eli Lilly and Company 71
Technology
• Implementation is rarely as easy as the vendor says
• Flexibility = complexity
• IT probably doesn’t know your business or your data
• Learn to speak “IT”
• No matter how sophisticated the software, you still
have to feed it good data
9/5/2019 ©2019 Eli Lilly and Company 72
Thank you!
Questions?
9/5/2019 ©2019 Eli Lilly and Company 73
CLINICAL TRIAL RISK AND PERFORMANCE
MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019
PHILADELPHIA, PA USA
Secrets to
Implementing
Successful Metric
Programs
Keith Dorricott
MCC Ambassador
Director, DMPI & DIGR-ACT
CLINICAL TRIAL RISK AND PERFORMANCE MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019 PHILADELPHIA, PA USA
Secrets to Implementing Successful Metric Programs
• Focus on the questions you are trying to answer
• Use existing standards where possible – much of the hard work
has already been done!
• Metric definitions – more than a metric title
• How MCC can help in metric selection
75
CLINICAL TRIAL RISK AND PERFORMANCE MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019 PHILADELPHIA, PA USA
MCC Metric Development Framework
76
Define Critical
Success
Factors (CSFs)
Define Key
Performance
Question (KPQ)
Define &
Measure Metric
to Answer KPQ
Generate Metric
Display that
Answers KPQ
Format display to highlight answer(s)
Define &
Measure Metric
to Answer KPQ
Generate Metric
Display that
Answers KPQ
Define Key
Performance
Question (KPQ)
Define &
Measure Metric
to Answer KPQ
Generate Metric
Display that
Answers KPQ
Develop
Process Map
©2019 Metrics Champion Consortium, All rights reserved
CLINICAL TRIAL RISK AND PERFORMANCE MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019 PHILADELPHIA, PA USA
Define Critical
Success
Factors (CSFs)
Define Key
Performance
Question (KPQ)
Define &
Measure Metric
to Answer KPQ
Generate Metric
Display that
Answers KPQ
Format display to highlight answer(s)
Define &
Measure Metric
to Answer KPQ
Generate Metric
Display that
Answers KPQ
Define Key
Performance
Question (KPQ)
Define &
Measure Metric
to Answer KPQ
Generate Metric
Display that
Answers KPQ
Develop
Process Map
©2019 Metrics Champion Consortium, All rights reserved
MCC Metric Development Framework
77
Metric Description: Percentage of initial supplies shipped by the target date
for the study
Critical Success Factor: Ready to take lab samples during the study
Key Performance Question: Are initial supplies shipped by the target date?
CLINICAL TRIAL RISK AND PERFORMANCE MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019 PHILADELPHIA, PA USA
Critical Success Factor:
Metric #Metric
Description
Key
Performance
Question to be
answered with
metric
Why is the Key Performance Question important?
What actions might be taken based upon results?
What the metric
does not tell you
Metric TypeReporting
Level
Basic/
AdvancedSub-Process Who is being measured?
Formula / Example
Performance
Target
(suggested)
Additional Analysis for Missed
Target
Companion
Metrics (Portfolio,
Study Country,
Site)
Reporting
Frequency
Glossary Terms (See Glossary Tab) Data Elements
78
©2019 Metrics Champion Consortium, All rights reserved
CLINICAL TRIAL RISK AND PERFORMANCE MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019 PHILADELPHIA, PA USA
Critical Success Factor:
Metric #Metric
Description
Key
Performance
Question to be
answered with
metric
Why is the Key Performance Question important?
What actions might be taken based upon results?
What the metric
does not tell you
Metric TypeReporting
Level
Basic/
AdvancedSub-Process Who is being measured?
Formula / Example
Performance
Target
(suggested)
Additional Analysis for Missed
Target
Companion
Metrics (Portfolio,
Study Country,
Site)
Reporting
Frequency
Glossary Terms (See Glossary Tab) Data Elements
79
New to MCC Metrics
Definitions
©2019 Metrics Champion Consortium, All rights reserved
CLINICAL TRIAL RISK AND PERFORMANCE MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019 PHILADELPHIA, PA USA
See MCC Metric Workbook for full
metric definition
Tool A: Key Performance Questions to Metrics Mapping Tool
80
©2019 Metrics Champion Consortium, All rights reserved
CLINICAL TRIAL RISK AND PERFORMANCE MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019 PHILADELPHIA, PA USA
See MCC Metric Workbook for full
metric definition
Data elements
Tool B: Issues to Metrics Mapping Tool
81
©2019 Metrics Champion Consortium, All rights reserved
CLINICAL TRIAL RISK AND PERFORMANCE MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019 PHILADELPHIA, PA USA
See MCC Metric Workbook for full
metric definition
Tool C: Basic/Advanced Metrics to Data Elements Mapping Tool
82
©2019 Metrics Champion Consortium, All rights reserved
CLINICAL TRIAL RISK AND PERFORMANCE MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019 PHILADELPHIA, PA USA
Tool D: Data Elements to Metrics Mapping Tool
See MCC Metric Workbook for full metric
definition
83
CLINICAL TRIAL RISK AND PERFORMANCE MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019 PHILADELPHIA, PA USA
Secrets to Implementing Successful Metric Programs
• Focus on the questions you are trying to answer
• Use existing standards where possible – much of the hard work
has already been done!
• Metric definitions – more than a metric title
• How MCC can help in metric selection
84
CLINICAL TRIAL RISK AND PERFORMANCE
MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019
PHILADELPHIA, PA USA
Secrets to
Implementing
Successful Metric
Programs
Keith Dorricott
MCC Ambassador
Director, DMPI & DIGR-ACT
CLINICAL TRIAL RISK AND PERFORMANCE
MANAGEMENT SUMMIT
SEPTEMBER 4-5, 2019
PHILADELPHIA, PA USA86
©2019 Metrics Champion Consortium, All rights reserved
Secrets to Implementing Successful
Metric Programs
• Deciding what to measure
• Establishing data requirements
• Aggregating reliable data — make or buy?
• Designing metric reports
• Using metrics to understand opportunities
to improve performance
• Future opportunities?